DIP
GILD icon

Davis Investment Partners’s Gilead Sciences GILD Stock Holding History

Davis Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$574K Sell
4,121
-354
-8% -$49.6K 0.2% 91
2025
Q4 		$544K Sell
4,475
-47
-1% -$5.71K 0.19% 87
2025
Q3 		$503K Sell
4,522
-669
-13% -$76K 0.17% 100
2025
Q2 		$580K Buy
5,191
+185
+4% +$19.7K 0.21% 93
2025
Q1 		$533K Buy
+5,006
New +$517K 0.24% 84

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Davis Investment Partners's GILD Position: Q1 2026 in Review

Davis Investment Partners reduced its Gilead Sciences (GILD) stake by 7.9% in Q1 2026, selling an estimated $49.6K and leaving 4,121 shares worth $574K. The position accounts for 0.2% of the portfolio, ranked #91.

Davis Investment Partners first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $580K in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Davis Investment Partners held 4,121 shares of Gilead Sciences worth $574K as of Q1 2026.
  • Davis Investment Partners sold 354 Gilead Sciences shares in Q1 2026, an estimated $49.6K.
  • Gilead Sciences made up 0.2% of Davis Investment Partners's portfolio in Q1 2026, its #91 holding.
  • Davis Investment Partners first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Davis Investment Partners's Gilead Sciences position peaked at $580K in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.